https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi?db=pubmed&term=Yushi+Ju%5Bauthor%5D&datetype=edat&usehistory=y&retmax=1&tool=pubfacts&email=info@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&WebEnv=MCID_67957a05dcaf867da8068383&query_key=1&retmode=xml&retstart=-10&retmax=25&tool=pubfacts&email=info@pubfacts.com&api_key=b8daa3ad693db53b1410957c26c9a51b4908
Publications by Yushi Ju | LitMetric
* The research introduces an oncolytic virus (VV-ΔTK-4L) designed to enhance immune response in the tumor microenvironment without causing liver damage, leading to longer survival in mice with pancreatic tumors.
* By increasing key immune cell populations and converting the tumor microenvironment from "cold" to "hot," combining VV-ΔTK-4L with PD-1/PD-L1 blockade significantly improves survival rates in mouse models of pancreatic cancer, showing promise for new therapeutic strategies.
